Cargando…

Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients

PURPOSE: This prospective clinical trial investigated sodium ((23)Na) MRI at 7 Tesla (T) field strength as biomarker for tumor extent, isocitrate dehydrogenase (IDH) mutation and O6-methylguanine DNA methyltransferase (MGMT) promotor methylation in glioma patients. METHODS: 28 glioma patients underw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Regnery, Sebastian, Behl, Nicolas G.R., Platt, Tanja, Weinfurtner, Nina, Windisch, Paul, Deike-Hofmann, Katerina, Sahm, Felix, Bendszus, Martin, Debus, Jürgen, Ladd, Mark E., Schlemmer, Heinz-Peter, Rieken, Stefan, Adeberg, Sebastian, Paech, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527584/ https://www.ncbi.nlm.nih.gov/pubmed/33002860 http://dx.doi.org/10.1016/j.nicl.2020.102427

Ejemplares similares

Assessment of Sodium MRI at 7 Tesla as Predictor of Therapy Response and Survival in Glioblastoma Patients
por: Paech, Daniel, et al.
Publicado: (2021)

Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients
por: Regnery, Sebastian, et al.
Publicado: (2018)

DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma
por: Adeberg, Sebastian, et al.
Publicado: (2022)

First application of dynamic oxygen-17 magnetic resonance imaging at 7 Tesla in a patient with early subacute stroke
por: Ebersberger, Louise, et al.
Publicado: (2023)

Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM)
por: Adeberg, Sebastian, et al.
Publicado: (2011)

Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff
por: Held, Thomas, et al.
Publicado: (2019)

7 Tesla and Beyond: Advanced Methods and Clinical Applications in Magnetic Resonance Imaging
por: Platt, Tanja, et al.
Publicado: (2021)

FAP-Specific Signalling Is an Independent Diagnostic Approach in ACC and Not a Surrogate Marker of MRI Sequences
por: Liew, Dawn P., et al.
Publicado: (2022)

Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location
por: Adeberg, Sebastian, et al.
Publicado: (2018)

Macroangiopathy is a positive predictive factor for response to immunotherapy
por: Deike-Hofmann, Katerina, et al.
Publicado: (2019)

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
por: Eichkorn, Tanja, et al.
Publicado: (2021)

Impact of (18)F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
por: Debus, Charlotte, et al.
Publicado: (2018)

Treatment of meningioma and glioma with protons and carbon ions
por: Adeberg, Sebastian, et al.
Publicado: (2017)

Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
por: Held, Thomas, et al.
Publicado: (2019)

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
por: Harrabi, Semi B, et al.
Publicado: (2014)

Sensitivity of different MRI sequences in the early detection of melanoma brain metastases
por: Deike-Hofmann, Katerina, et al.
Publicado: (2018)

Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation
por: Weusthof, Katharina, et al.
Publicado: (2021)

Clinical Results of Fibroblast Activation Protein (FAP) Specific PET and Implications for Radiotherapy Planning: Systematic Review
por: Windisch, Paul, et al.
Publicado: (2020)

Survival and recurrence patterns of multifocal glioblastoma after radiation therapy
por: Syed, Mustafa, et al.
Publicado: (2018)

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
por: Combs, Stephanie E, et al.
Publicado: (2011)

Clinical results of fibroblast activation protein (FAP) specific PET for non-malignant indications: systematic review
por: Windisch, Paul, et al.
Publicado: (2021)

Do Increased Doses to Stem-Cell Niches during Radiation Therapy Improve Glioblastoma Survival?
por: Adeberg, Sebastian, et al.
Publicado: (2016)

Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility Study
por: Adeberg, Sebastian, et al.
Publicado: (2021)

Ways to unravel the clinical potential of carbon ions for head and neck cancer reirradiation: dosimetric comparison and local failure pattern analysis as part of the prospective randomized CARE trial
por: Held, Thomas, et al.
Publicado: (2022)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
por: Regnery, Sebastian, et al.
Publicado: (2020)

Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis
por: Jungk, Christine, et al.
Publicado: (2016)

Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist’s point of view
por: Foerster, Robert, et al.
Publicado: (2015)

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Intensity Modulated Radiotherapy (IMRT) With Carbon Ion Boost in the Multimodal Treatment of Salivary Duct Carcinoma
por: Adeberg, Sebastian, et al.
Publicado: (2019)

Bimodality treatment of patients with pelvic adenoid cystic carcinoma with photon intensity-modulated radiotherapy plus carbon ion boost: a case series
por: Bernhardt, Denise, et al.
Publicado: (2018)

Carbon-ion radiotherapy in accelerated hypofractionated active raster-scanning technique for malignant lacrimal gland tumors: feasibility and safety
por: Akbaba, Sati, et al.
Publicado: (2019)

Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience
por: Akbaba, Sati, et al.
Publicado: (2019)

Location-Dependent Patient Outcome and Recurrence Patterns in IDH1-Wildtype Glioblastoma
por: Jungk, Christine, et al.
Publicado: (2019)

Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
por: Kessler, Tobias, et al.
Publicado: (2020)

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability
por: Held, Thomas, et al.
Publicado: (2022)

Post-Surgical Depositions of Blood Products Are No Major Confounder for the Diagnostic and Prognostic Performance of CEST MRI in Patients with Glioma
por: von Knebel Doeberitz, Nikolaus, et al.
Publicado: (2023)

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations
por: Regnery, Sebastian, et al.
Publicado: (2022)

Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution’s Clinical Experience
por: Liermann, Jakob, et al.
Publicado: (2018)

Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control
por: Akbaba, Sati, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n8g5nam4td2hsn42bcr7ksnvj3